Board of Directors
Dr. Reza discovered and pioneered the PARS® imaging techniques. In November 2014, he co-founded illumiSonics inc., holding the position of CEO from November 2014 to March 2018. Dr. Reza is an award winning professor at the University of Waterloo and leads a team of technical experts at PhotoMedicine Labs. He brings more than 10 years experience in optics and biomedical engineering, and continues to advance the validation of PARS® through these efforts. He currently has 35+ peer reviewed journal papers in optics and biomedical Engineering. He also holds 7 family of patents regarding PARS® technology. Dr. Reza has been recognized for his innovative scientific contributions to advancing the state of optical imaging.
|
Dr. Mackey is a medical oncologist and Director of Clinical Trials Unit at the Cross Cancer Institute in Edmonton, Canada, and a Professor of Oncology at the University of Alberta. In addition to acting as director and lead clinical advisor to illumiSonics, Dr. Mackey brings deep medtech commercialization experience. He co-founded Pacylex Pharmaceuticals, J2 Endeavours, and SMHeartCard Inc. As Chair of the Alberta Pre-Phase I Program steering committee, he has a highly skilled team committed to bringing new anticancer therapies into clinical testing (www.prephaseone.com). Dr. Mackey has authored or co-authored more than 300 biomedical peer reviewed publications.
|
Mr. Johnson has been the Chief Executive of a number of companies primarily in the technology sector. He was the co-founder and CEO of Intuit Canada and UK and grew that organization to 700 staff and revenues of around $115M. He currently is active in coaching entrepreneurs and sits on a number of boards including Campbell Scientific Canada, HeadCount Corporation, Visio Media Inc., Social Asset Management Inc., Rehabtronics Inc., and the Alberta Machine Intelligence Institute.
|
Dr. Fahey has held executive positions in both large and small companies, and in all cases has driven dramatic growth time and time again. At Xradia (acquired by ZEISS) and FEI (acquired by ThermoFisher), Dr. Fahey grew the business over 4X within 4 years by restructuring their existing products, solutions and operations. He drove entry into new markets, and implemented efficient sales, marketing, and management systems that enabled the businesses to scale into the future. Dr. Fahey grew startup businesses from pre-revenue to commercialization at ESI, Metrosol, and OptoAtmospherics, including landing large B2B customers. Dr. Fahey successfully pivoted ESI, KMLabs, ZEISS into new markets, creating new business lines and implementing integrated sales and marketing channels that drove rapid increases in sales. Dr. Fahey holds a Ph.D. in Materials Science and Engineering from Stanford University and a B.S. in Physics from the Massachusetts Institute of Technology.
|